New York City's first Ebola case has raised complex issues of how to trace the possible contacts of an infected patient, the NYT reports.» Read More
The car-service announced a one-day pilot program in partnership with Harvard Medical School to deliver free flu shots on-demand, NBC News reports.
A new email malware pretends to provide information about the disease, but it actually infects the computer with malicious programs.
Biotech firm Celgene performed strongly in the third quarter beating analyst estimates for earnings and sales.
Eli Lilly earnings plunged, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its full-year forecast.
Drugmakers are seeking indemnity against possible losses from the widespread emergency use of new Ebola vaccines in Africa.
The Dallas hospital that treated three Ebola patients has seen steep drop offs in patients and revenue since Oct. 1, a new report reveals.
Language in contracts health insurers must sign to sell coverage on HealthCare.gov will let them terminate their plans if premium subsidies cease.
The patient, who was taking Tecfidera, died earlier this month.
Several medical devices are being inspected for cybersecurity flaws by the The Department of Homeland Security.
Former U.N. Secretary General has warned that a "dark cloud" could be cast over Africa if the press continued its scaremongering over Ebola.
GlaxoSmithKline (GSK) reported third-quarter revenue lower than analysts forecast, as sales of blockbuster asthma drug Advair continued to fall.
CVS Health is developing a new tobacco-free pharmacy network and will charge clients who fill prescriptions at stores that sell tobacco.
Nine in 10 uninsured Americans don't know that Obamacare's next open-enrollment period starts next month, a Kaiser survey finds.
A new Ebola vaccine could be ready to send to West Africa soon, NewLink Genetics' Charles Link says.
A Bulgarian man who was paralyzed can walk with the aid of a frame after receiving transplant treatment using cells from his nose.
AbbVie is walking away from its proposed $55 billion takeover bid of Shire and has agreed to pay the rival drugmaker a $1.64 billion breakup fee.
Here is the most crucial element to stopping the spread of Ebola, says Scott Ratzan, a doctor and member of the CDC board on infectious disease.
A doctor treated for Ebola was released from an Atlanta hospital and 43 people were taken off Dallas' Ebola watch list.
While very fast-mutating, Ebola is unlikely to become transmissible through the air, said Richard Preston, author of the "The Hot Zone."
The first wave of people who had contact with the original Dallas Ebola patient who died were taken off a watch list early Monday.
Get the best of CNBC in your inbox